Cancer Biomarkers Funding Opportunities
Title |
Announcement # | Expiration Date | Activity Code | Contact |
|---|---|---|---|---|
| AHEAD (Advancing Head and Neck Cancer Early Detection Research) | RFA-DE-23-013 (U01 Clinical Trial Not Allowed) | 03/15/2023 | U01 | Wendy Wang, Ph.D., M.Sc. |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-314 (UH3 Clinical Trials Not Allowed) | 10/11/2023 | UH3 | Lynn Sorbara, Ph.D. |
| Assay Validation of High Quality Markers for Clinical Studies in Cancer | PAR-20-313 (UH2/UH3 Clinical Trial Not Allowed) | 10/11/2023 | UH2, UH3 | Lynn Sorbara, Ph.D. |
| Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research | PAR-22-099 (R01 Clinical Trial Optional) | 05/08/2025 | R01 | Richard Mazurchuk, Ph.D. |
| Co-infection and Cancer | PAR-20-062 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Jo Ann Rinaudo, Ph.D. |
| Notice of Correction to Application Types Allowed for PAR-20-053, Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | NOT-CA-20-067 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Matthew Young, Ph.D. |
| Notice of Special Interest: Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed) | NOT-OD-22-202 | 04/16/2025 | Nancy J. Emenaker, Ph.D., R.D.N., L.D., F.A.N.D. | |
| Notice of Special Interest (NOSI): Leveraging Real-World Imaging Data for Artificial Intelligence-based Modeling and Early Detection of Abdominal Cancers | NOT-CA-21-028 | 01/08/2024 | Natalie Abrams, Ph.D. | |
| Notice of Special Interest (NOSI): Single-Cell Proteomics for Interrogating Premalignant and Early Malignant Lesions | NOT-CA-20-044 | 05/08/2023 | Richard Mazurchuk, Ph.D | |
| Notice of Special Interest (NOSI): Utilization of Cohorts and Prospective Study Designs for Liquid Biopsy Assay Validation for Early Detection of Cancers | NOT-CA-23-004 | 07/02/2025 | Matthew Young, Ph.D. | |
| Pancreatic Cancer Detection Consortium: Research Units | PAR-21-334 (U01 Clinical Trial Optional) | 06/12/2024 | U01 | Sharmistha Ghosh-Janjigian, Ph.D. |
| Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection | PAR-20-053 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Matthew Young, Ph.D. |
| Request for Information (RFI) on Challenges and Opportunities Associated with Multidimensional Tumor Atlases | NOT-CA-23-011 | 01/07/2023 | Shannon K. Hughes, Ph.D. | |
| Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes | PAR-20-276 (R01 Clinical Trial Not Allowed) | 01/08/2023 | R01 | Wendy Wang, Ph.D., M.Sc. |